Paratek raises $18 million

Infectious disease company Paratek (Boston, Mass.) raised $18 million in the second and final tranche of a series H round, bringing the total raised in the round to $40 million. Aisling led the financing, as previously announced, with additional participation by the investors from the first tranche: D.E. Shaw Group; Boston Life Science; Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier; BioVeda; and Hercules Technology Growth Capital. Pacific Growth Equities served as placement agent. ...